Last year Americans flew to China for a $10,000 cancer drug. Now it's $200,000.
kept by novascribe
AstraZeneca will sell a Chinese-developed lung cancer drug in the US for $160,000–$230,000, up from $10,000 in China, after Americans previously flew to China to buy it.